Dibenzo(a,h)anthracene cas no:53-70-3
Synonyms: 1,2:5,6-Benzanthracene;1,2:5,6-Dibenz[a]anthracene; 1,2:5,6-Dibenzanthracen; 1,2:5,6-Dibenzanthracene;1,2:5,6-Dibenzoanthracene; DBA; Dibenzo[a,h]anthracene; NSC 22433
NameDibenzo(a,h)anthracene
CAS53-70-3
Synonyms1,2:5,6-Benzanthracene;1,2:5,6-Dibenz[a]anthracene; 1,2:5,6-Dibenzanthracen; 1,2:5,6-Dibenzanthracene;1,2:5,6-Dibenzoanthracene; DBA; Dibenzo[a,h]anthracene; NSC 22433
EINECS(EC#)200-181-8
Molecular FormulaC22H14
Molecular Weight278.3466
refractive index1.811
storage tempAPPROX 4°C
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(b)
Hazard A confirmed carcinogen. A poison.
Risk 45-50/53-67-65-38-11
Safety
Confirmed carcinogen with experimental carcinogenic, tumorigenic, and neoplastigenic data. Poison by intravenous route. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes T,N,F
Risk Statements 45-50/53-67-65-38-11
Safety Statements 53-45-60-61-62
Hazard Codes:
T
N
F
Risk Statements about Dibenz(a,h)anthracene (CAS No.:53-70-3):
R11:Highly flammable.
R38:Irritating to skin.
R45:May cause cancer.
R65:Harmful: may cause lung damage if swallowed.
R67:Vapours may cause drowsiness and dizziness.
R50/53:Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Safety Statements about Dibenz(a,h)anthracene (CAS No.:53-70-3):
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S53:Avoid exposure - obtain special instructions before use.
S60:This material and its container must be disposed of as hazardous waste.
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.
S62:If swallowed, do not induce vomitting; seek medical advice immediately and show this container or label.
1. |
|
dnd-hmn:emb 360 nmol/L
|
|
CBINA8 Chemico-Biological Interactions. 22 (1978),257. |
2. |
|
dnd-esc 10 µmol/L
|
|
MUREAV Mutation Research. 89 (1981),95. |
3. |
|
otr-rat-orl 200 mg/kg
|
|
CNREA8 Cancer Research. 40 (1980),1157. |
4. |
|
msc-mus:lym 4250 µg/L
|
|
MUREAV Mutation Research. 106 (1982),101. |
5. |
|
msc-ham:lng 500 µg/L
|
|
MUREAV Mutation Research. 136 (1984),65. |
6. |
|
ivn-mus LDLo:10 mg/kg
|
|
JNCIAM Journal of the National Cancer Institute. 1 (1940),225. |